Literature DB >> 17123727

Interleukin-18 mediated inhibition of LTP in the rat dentate gyrus is attenuated in the presence of mGluR antagonists.

Derval Cumiskey1, Mark Pickering, John J O'Connor.   

Abstract

Pro-inflammatory cytokines are known to be elevated in several neuropathological states that are associated with learning and memory impairments. We have previously demonstrated the inhibition of long-term potentiation (LTP), a recognised model for memory, in the dentate gyrus region of the rat hippocampus, by interleukin-18. We have also previously shown that the inhibitory effect of TNF-alpha on LTP can be attenuated by inhibitors of metabotropic glutamate receptors (mGluRs). We therefore went on to investigate the effects of the mGluR antagonists MPEP and MTPG on the effect of IL-18 on LTP in the rat dentate gyrus in vitro. Recordings of field excitatory post-synaptic potentials (EPSPs) were made from the medial perforant path of rat hippocampal slices. IL-18 (100 ng/ml) applied for 20 min before-HFS had no significant effect on baseline EPSPs but significantly impaired LTP (IL-18 LTP 116+/-9%, versus control LTP 163+/-6% 1h post-tetanus, P<0.001, n=5). Perfusion of the mGluR5 specific antagonist MPEP (5 microM) for 40 min prior to application of IL-18 had no significant effect on baseline EPSPs but significantly attenuated the inhibitory effect of IL-18 on LTP at 30 min but not 1h (177+/-2% and 138+/-8%, respectively, compared to controls; n=5). Perfusion of the group II mGluR antagonist MTPG (50 microM) for 40 min prior to application of IL-18 had no significant effect on baseline EPSPs but was found to significantly reverse the inhibitory effect of IL-18 on LTP at 1h (164+/-6% compared to IL-18 alone, n=5). This study provides novel evidence of the involvement of mGluRs in the IL-18 mediated inhibition of LTP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17123727     DOI: 10.1016/j.neulet.2006.11.007

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Alternatively activated myeloid (M2) cells enhance cognitive function in immune compromised mice.

Authors:  Noel C Derecki; Kayla M Quinnies; Jonathan Kipnis
Journal:  Brain Behav Immun       Date:  2010-11-18       Impact factor: 7.217

2.  Exploratory Investigation of Early Biomarkers for Chronic Fatigue in Prostate Cancer Patients Following Radiation Therapy.

Authors:  Li Rebekah Feng; Brian S Wolff; Nada Lukkahatai; Alexandra Espina; Leorey N Saligan
Journal:  Cancer Nurs       Date:  2017 May/Jun       Impact factor: 2.592

Review 3.  The biology of cancer-related fatigue: a review of the literature.

Authors:  Leorey N Saligan; Karin Olson; Kristin Filler; David Larkin; Fiona Cramp; Sriram Yennurajalingam; Yennu Sriram; Carmen P Escalante; Auro del Giglio; Kord M Kober; Jayesh Kamath; Oxana Palesh; Karen Mustian
Journal:  Support Care Cancer       Date:  2015-05-15       Impact factor: 3.603

Review 4.  Innate immunity in Alzheimer's disease.

Authors:  Michael T Heneka; Douglas T Golenbock; Eicke Latz
Journal:  Nat Immunol       Date:  2015-03       Impact factor: 25.606

5.  Interleukin-18 null mutation increases weight and food intake and reduces energy expenditure and lipid substrate utilization in high-fat diet fed mice.

Authors:  Eric P Zorrilla; Bruno Conti
Journal:  Brain Behav Immun       Date:  2013-12-06       Impact factor: 7.217

6.  Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain.

Authors:  Silvia Alboni; Claudia Montanari; Cristina Benatti; Johanna M C Blom; Maria Luisa Simone; Nicoletta Brunello; Federica Caggia; Gianluigi Guidotti; Maria Cecilia Garibaldi Marcondes; Manuel Sanchez-Alavez; Bruno Conti; Fabio Tascedda
Journal:  Brain Behav Immun       Date:  2010-11-24       Impact factor: 7.217

Review 7.  Interleukin 18 in the CNS.

Authors:  Silvia Alboni; Davide Cervia; Shuei Sugama; Bruno Conti
Journal:  J Neuroinflammation       Date:  2010-01-29       Impact factor: 8.322

8.  Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain.

Authors:  Silvia Alboni; Davide Cervia; Brendon Ross; Claudia Montanari; Alejandro Sanchez Gonzalez; Manuel Sanchez-Alavez; Maria Cecilia Garibaldi Marcondes; David De Vries; Shuei Sugama; Nicoletta Brunello; Joan Blom; Fabio Tascedda; Bruno Conti
Journal:  J Neuroimmunol       Date:  2009-07-28       Impact factor: 3.478

9.  TNFα and IL-1β but not IL-18 Suppresses Hippocampal Long-Term Potentiation Directly at the Synapse.

Authors:  G Aleph Prieto; Liqi Tong; Erica D Smith; Carl W Cotman
Journal:  Neurochem Res       Date:  2018-04-04       Impact factor: 3.996

Review 10.  Neuro-Immune Cross-Talk in the Striatum: From Basal Ganglia Physiology to Circuit Dysfunction.

Authors:  Andrea Mancini; Veronica Ghiglieri; Lucilla Parnetti; Paolo Calabresi; Massimiliano Di Filippo
Journal:  Front Immunol       Date:  2021-04-19       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.